Online edition of India's National Newspaper
Tuesday, Feb 10, 2009
ePaper | Mobile/PDA Version
Google



International
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary |

International Printer Friendly Page   Send this Article to a Friend

Drug by using genetically modified animals

Todd Wallack


The herd secretes a therapeutic protein

— Photo: AP

Goats at the GTC Farm.

A Framingham biotech company has become the first to win federal approval to manufacture a drug by using genetically modified animals, an approach that could eventually be used to produce many drugs using farm animals.

The US Food and Drug Administration has approved GTC Biotherapeutics Inc.’s ATryn, an anticlotting drug made using genetically modified goats that live on a farm in Charlton. GTC engineered the herd to secrete a special therapeutic protein in their milk.

“It’s really a milestone event,” said Eric Overstrom, chairman of biology and biotechnology at Worcester Polytechnic Institute, who collaborated with GTC on some of its early research using goats. “This adds to the toolbox for the pharmaceutical industry.”

Though ATryn is likely to have limited marketing potential because it would serve a relatively small pool of patients, the drug’s approval could clear the way to produce many more drugs with genetically modified animals, an approach nicknamed “pharming.” Mr. Overstrom said drug companies could also potentially use other animals such as cows or rabbits to produce drugs in their milk, blood, or even urine. He said animals could be particularly helpful in cultivating enzymes and other large molecules that are more difficult to produce using bacteria or individual cells.

Still, some activists are wary about the use of genetically engineered animals. The Center for Food Safety, a nonprofit group, complained that the animals could pose unforeseen health and environmental risks.

“The creation of GE animals is a very slippery slope,” Jaydee Hanson, the centre’s policy analyst on cloning and genetics, said in a statement.

“All it takes is one mating between an escaped specimen and a natural animal to set off a chain of events that could lead to contamination or extinction.” — New York Times News Service

Printer friendly page  
Send this article to Friends by E-Mail



International

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Ergo | Home |

Copyright © 2009, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu